Minor
MB04 [Proposed Etanercept Biosimilar] to Enbrel® [EU-sourced] in Rheumatoid Arthritis
Trial completed
Also in this update: Primary completion date changed from estimate of Oct 2025 to Feb 20, 2026
mAbxience Research S.L.Phase 3 NCT06596772 Registry history of NCT06596772 on ClinicalTrials.gov (opens the registry)